Literature DB >> 23313550

Piperine decreases pilocarpine-induced convulsions by GABAergic mechanisms.

Giovany Michely Pinto da Cruz1, Cícero Francisco Bezerra Felipe, Fúlvio Alexandre Scorza, Marta Aline Coelho da Costa, Alinne Farias Tavares, Maria Luiza Feitosa Menezes, Geanne Matos de Andrade, Luzia Kalyne A M Leal, Gerly Anne C Brito, Maria da Graça Naffah-Mazzacoratti, Esper Abrão Cavalheiro, Glauce Socorro de Barros Viana.   

Abstract

Piperine, an alkaloid present in the Piper genus, was shown to have an anticonvulsant activity, evaluated by the pilocarpine-induced model, in mice. Pilocarpine (350mg/kg, i.p.) was administered 30min after piperine (2.5, 5, 10 and 20mg/kg, i.p.) which significantly increased latencies to 1st convulsion and to death, and percentage of survivals. These parameters were also increased in the pilocarpine groups pretreated with atropine plus piperine (10 and 2.5mg/kg, respectively), as related to the pilocarpine group. However, they were not altered in the pilocarpine groups pretreated with memantine (a NMDA-type glutamate receptors blocker, 2mg/kg, p.o.) or nimodipine (a calcium channel blocker, 10mg/kg, p.o.), both associated with piperine (1 or 2.5mg/kg), as compared to the piperine plus pilocarpine group. Moreover, the pilocarpine group pretreated with diazepam (which binds to the GABAA receptor, 0.2 and 0.5mg/kg, i.p.) plus piperine (1 and 2.5mg/kg) significantly increased latency to the 1st convulsion, as related to the pilocarpine group, suggesting that the GABAergic system is involved with the piperine action. Furthermore, the piperine effect was blocked by flumazenil (2mg/kg, i.p.), a benzodiazepine antagonist. Untreated P350 animals showed decreased striatal DA and increased DOPAC and HVA levels that were not affected in the piperine plus pilocarpine groups. Piperine increased striatal levels of GABA, glycine and taurine, and reversed pilocarpine-induced increases in nitrite contents in sera and brain. Hippocampi from the untreated pilocarpine group showed an increased number of TNF-α immunostained cells in all areas, as opposed to the pilocarpine group pretreated with piperine. Taken together, piperine anticonvulsant effects are the result of its anti-inflammatory and antioxidant actions, as well as TNF-α reduction. In addition, piperine effects on inhibitory amino acids and on the GABAergic system may certainly contribute to the drug anticonvulsant activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313550     DOI: 10.1016/j.pbb.2013.01.002

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  14 in total

Review 1.  Awareness and current knowledge of epilepsy.

Authors:  Asmat Ullah Khan; Muhammad Akram; Muhammad Daniyal; Naheed Akhter; Muhammad Riaz; Naheed Akhtar; Mohammad Ali Shariati; Fozia Anjum; Samreen Gul Khan; Abida Parveen; Saeed Ahmad
Journal:  Metab Brain Dis       Date:  2019-10-11       Impact factor: 3.584

2.  Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats.

Authors:  Tianjing Ren; Min Xiao; Mengbi Yang; Jiajia Zhao; Yufeng Zhang; Mengyun Hu; Yan Cheng; Hong Xu; Chunbo Zhang; Xiaoyu Yan; Zhong Zuo
Journal:  AAPS J       Date:  2019-07-18       Impact factor: 4.009

3.  Role for pro-inflammatory cytokines in regulating expression of GABA transporter type 1 and 3 in specific brain regions of kainic acid-induced status epilepticus.

Authors:  Jing Su; Jian Yin; Wei Qin; Suxu Sha; Jun Xu; Changbin Jiang
Journal:  Neurochem Res       Date:  2015-02-24       Impact factor: 3.996

Review 4.  A Pharmacological Perspective on Plant-derived Bioactive Molecules for Epilepsy.

Authors:  Javad Sharifi-Rad; Cristina Quispe; Jesús Herrera-Bravo; Miquel Martorell; Farukh Sharopov; Tugba Boyunegmez Tumer; Begum Kurt; Chintha Lankatillake; Anca Oana Docea; Ana Catarina Moreira; Daniel A Dias; Mohamad Fawzi Mahomoodally; Devina Lobine; Natália Cruz-Martins; Manoj Kumar; Daniela Calina
Journal:  Neurochem Res       Date:  2021-06-12       Impact factor: 3.996

5.  Anticonvulsant mechanisms of piperine, a piperidine alkaloid.

Authors:  Awanish Mishra; Jasmine Kaur Punia; Chris Bladen; Gerald W Zamponi; Rajesh Kumar Goel
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

6.  S(+)-(2E)-N-(2-Hydroxypropyl)-3-Phenylprop-2-Enamide (KM-568): A Novel Cinnamamide Derivative with Anticonvulsant Activity in Animal Models of Seizures and Epilepsy.

Authors:  Agnieszka Gunia-Krzyżak; Ewa Żesławska; Karolina Słoczyńska; Dorota Żelaszczyk; Aleksandra Sowa; Paulina Koczurkiewicz-Adamczyk; Justyna Popiół; Wojciech Nitek; Elżbieta Pękala; Henryk Marona
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

7.  Insights about multi-targeting and synergistic neuromodulators in Ayurvedic herbs against epilepsy: integrated computational studies on drug-target and protein-protein interaction networks.

Authors:  Neha Choudhary; Vikram Singh
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

8.  Piperine Improves Experimental Autoimmune Encephalomyelitis (EAE) in Lewis Rats Through its Neuroprotective, Anti-inflammatory, and Antioxidant Effects.

Authors:  Reza Nasrnezhad; Sohrab Halalkhor; Farzin Sadeghi; Fereshteh Pourabdolhossein
Journal:  Mol Neurobiol       Date:  2021-08-02       Impact factor: 5.590

Review 9.  Efficacy of Iranian traditional medicine in the treatment of epilepsy.

Authors:  Mehri Abdollahi Fard; Asie Shojaii
Journal:  Biomed Res Int       Date:  2013-07-07       Impact factor: 3.411

10.  Piperine Plays an Anti-Inflammatory Role in Staphylococcus aureus Endometritis by Inhibiting Activation of NF-κB and MAPK Pathways in Mice.

Authors:  Wen-Jun Zhai; Zhen-Biao Zhang; Nian-Nian Xu; Ying-Fang Guo; Changwei Qiu; Cheng-Ye Li; Gan-Zhen Deng; Meng-Yao Guo
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.